Amicon concentrator using a YM 10 membrane (Amicon Corp., Lexington, MA), followed by sequential precipitation with 40 and 90% ammonium sulfate. The 90% ammonium sulfate precipitate was dissolved in a small volume of Dulbecco's phosphate-buffered saline (PBS), dialyzed extensively against the same buffer, and then fractionated by gel filtration on a Sephadex G150 column that had been equilibrated with Duibecco's PBS. Each fraction was examined for its BSF-pl, IL-2, and EL-TRF activities. BSF-pl activity was tested in a B cell costimulator assay described elsewhere (1) . IL-2 activity was measured by the stimulation of uptake of [SH] thymidine by an IL-2-dependent cell line (HT-2) (16). 1 U of 1L-2 is defined as the amount required to cause half-maximal uptake of [~H]-thymidine by 4 x l0 s HT-2 cells in the last 4 h of a 28 h culture period. EL-TRF activity was determined as described below.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE). Samples (frac-
tions 52-54) from Sephadex G150 column chromatography containing peak EL-TRF activity were further fractionated by slab gel SDS-PAGE (17) . The samples were dialyzed for 16 h against sample buffer that contained Tris-HCl (pH 6.8), 1% SDS, and 10% glycerol. A running buffer system of Tris-glycine, containing 0.1% SDS, pH 8.5 was used. The stacking gel contained Tris-HCI (pH 6.8) and 4% polyacrylamide. The separation gel contained Tris-HCl (pH 8.8) and 12.5 % polyacrylamide. After electrophoresis at room temperature, the gel was sliced into 2.0-mm-wide fractions. The gel slices were electroeluted, in the presence of 1% bovine serum albumin. Samples were dialyzed at room temperature against PBS followed by dialysis against 4.0 M urea to remove the SDS. They were then dialyzed at 4°C against PBS and finally against RPMI 1640 medium containing 1% FCS. Each fraction was made sterile by filtration and examined for its BSF-pl, IL-2, and EL-TRF activities. B Cell Preparation. We prepared B cells by pretreatment of donor mice with antithy-mocyte serum followed by passage of spleen cells over a Sephadex G10 column and two rounds of complement-mediated lysis with monoclonal anti-Thy-1.2 and anti-Lyt-1.2 (18) .
In most experiments, positive selection, by adherence to and elution from plastic dishes coated with anti-IgM antibodies (19) , was coupled to this negative selection procedure. Flow microfluorometric analysis on a fluorescence-activated cell sorter (FACS II; B-D FACS Systems, Sunnyvale, CA) showed that the cell populations obtained by these sequential purification procedures were ~99% surface IgM positive.
Assay for IgM-Synthesizing Cells. 2 X 105 purified B cells were cultured in flat-bottom, 96-well microtiter plates (No. 3596; Costar, Cambridge, MA) in 0.2 ml of medium containing 5 #g/ml of goat anti-IgM and various combinations of factors. The assay for EL-TRF activity was performed by culturing B cells with anti-IgM, BSF-pl, B15-TRF, and fractions to be examined for their EL-TRF activity. After 4-5 d of culture, a quantitative immunoassay for cytoplasmic IgM content was performed by using an enzymelinked immunoadsorbent assay (ELISA) method (20) . Cells in culture plates were washed four times with Hanks' balanced salt solution (HBSS). Nonidet P-40 (NP-40) was added to each well at a concentration of 0.25% to make cell lysates that were used for the detection of cytoplasmic IgM. Two rat monoclonal anti-mouse # heavy chain antibodies (Bet-1 and Bet-2) (21) were used. Bet-1 was used for coating the microtiter plates and biotinylated Bet-2 was used as a second antibody to detect IgM bound to the Bet-l-coated plate. After extensive washing of the plates, a horseradish peroxidase-avidin conjugate was added to each well, followed by incubation with substrate. In some cases, the presence of cytoplasmic IgM was determined by immunofluoresence as described previously (4) .
RNA Preparation from Resting B Cells and Cultured B Cells. After 4 d of culture, multiple wells from each group were combined and the viable cell number was determined by using the trypan blue dye exclusion method. Cell number was adjusted to 3 x 106 per group. Total RNA was obtained by lysis with 0.5% NP-40 of 3 × 106 resting B cells that had been cultured for 48 h and of 3 x 106 B cells stimulated for 4 d with anti-IgM and T cell-derived factors. After cell lysis, total RNA was extracted with cold phenol (twice) and chroloform/isoamylalcohol(24:1) (once) sequentially, and then ethanol precipitated. RNA was dotted onto nitrocellulose paper, fixed by baking, and then hybridized with a 3~p. labeled cDNA clone specific for the secretory terminal of the # chain and the 3' untranslated region immediately following the terminus. This cDNA was subcloned from p#l 2; p#l 2 was kindly provided to us by R. Wall (22) . The specificity of the subcloned probe is described elsewhere (22a). After washing twice with 0.3 M NaC1/0.03 M trisodium citrate (2× SSC) and twice with 0.2x SSC, the filter was exposed to Kodak XAR-5 x-ray film at -70 °C using an intensifying screen.
Fluorescence Staining of B Cells Stimulated with Anti-IgM Plus T Cell-Derived Factors. Direct fluorescent staining was performed by incubating the cells (1 x 106) for 30 min at 4°C with 1-2 #g of fluorescein-isothiocyanate-conjugated monoclonal antibody. After incubation, cells were washed three times with HBSS containing 0.1% NaN3 and 3% FCS, and then analyzed on a FACS. The capacity of unconjugated 3C7 and 7D4 to compete in this binding was also assessed on the FACS; 2 x 105 cells were first incubated with the supernatants containing the indicated monoclonal antibodies followed by an additional incubation with 1-2 #g of FITC-conjugated 3C7 or FITC-conjugated 7D4. The samples were then washed and analyzed on the FACS. 10,000-20,000 cells were analyzed for each determination. Dead cells, identified by staining with propidium iodide, were excluded from analysis. Indirect fluorescent staining was performed as previously described (13) by incubating the cells (1 x 106) with an excess of culture supernatant fluids containing the indicated monoclonal antibodies. After washing and subsequent staining with FITC-conjugated MAR 18.5, the samples were analyzed on a FACS.
Radiolabeled IL-2-bindingAssay. Biosynthetically radiolabeled [SH]leu,lys-IL-2 ([SH]IL-2) was prepared as described previously (23) . The purification of human IL-2 was performed by using affinity chromatography. The eluted material was comprised of a single polypeptide (15,500 mol wt) when analyzed by SDS-PAGE, reverse phase liquid chromatography, and amino-terminal amino acid sequence analysis (24) . Radiolabeled IL-2 binding to whole cells was performed as described in detail previously (23) .
Results

A Portion of the EL-TRF Activity in EL-4 Supernatants Co-migrates with IL-2.
High rate IgM synthesis by rigorously purified B cells stimulated with anti-IgM antibodies depends upon the presence of three T cell-derived factors: BSF-pl, B 15-TRF, and EL-TRF. Omission of any one of these factors leads to a meager response but when all three factors are present, 10-30% of the resulting B cells contain substantial amounts of cytoplasmic IgM (4). In the experiment illustrated in Fig. 1 , the total concentration of cytoplasmic IgM in lysates of cells stimulated with all three factors was 2.35 #g/ml, whereas stimulation of cell with any mixture of two factors led to concentrations of cytoplasmic IgM ranging from 0.15 to 0.81 ~g/ml.
In an effort to characterize EL-TRF, we added graded concentrations of ammonium sulfate to supernatants of EL-4 cells and took the material that was soluble at 40% ammonium sulfate but precipitated at 00% ammonium sulfate. This fraction contained the bulk of the EL-TRF activity. After dialysis against PBS, this material was applied to a Sephadex G-150 column. Samples were tested for EL-TRF, BSF-pl, and IL-2 activity (Fig. 2) . EL-TRF activity was found in two portions of the chromatogram, one with an apparent molecular weight of 32,000 and the other, 16,000. IL-2 activity was equally distributed between Gel filtration of EL-TRF. Induced EL-4 supernatant, after ammonium sulfate precipitation (see Materials and Methods), was applied to a Sephadex G-150 column. Individual fractions (2 ml) were tested for OD~a0, IL-2, BSF-pl, and EL-TRF activity. The column had previously been calibrated with sheep gamma globulin (SGG; tool wt 155,000), bovine serum albumin (BSA; tool wt 68,000), and ovalbumin (OVA; mol wt 43,000).
these two fractions, while the bulk of the BSF-pl activity was found in the lower molecular weight fraction.
Since the higher molecular weight peak had considerably more EL-TRF activity than the lower molecular weight peak, we concentrated our attention on this material. Fractions 52, 53, and 54, from the higher molecular weight peak, were pooled, concentrated, and applied to a SDS-polyacrylamide gel (12.5% acrylamide). After electrophoresis, EL-TRF, IL-2, and BSF-pl activities in individual gel slices were measured. EL-TRF activity was found in two areas of the electropherogram, one corresponding to 32,000 (fraction 13), the other, 16,000 (fraction 22) (Fig. 3 ). We will designate the former material as high molecular weight EL-TRF and the latter as low molecular weight EL-TRF. IL-2 and BSFpl activity were found only in the lower molecular weight fraction. Thus, EL-TRF appears to exist in two forms, separable by SDS-PAGE. One of the two, low molecular weight EL-TRF, co-migrates with IL-2 and BSF-pl; the other, high molecular weight EL-TRF, is well separated from these two factors.
IL-2 Has EL-TRF Activity. To further explore the relationship between IL-2 and EL-TRF, we tested the ability of a monoclonal antibody to the murine IL-2 receptor to inhibit the differentiative activity of EL-TRF. 3C7 has been shown to inhibit the action of IL-2 on activated T cells, to block the binding of [SH]IL-2 to the IL-2 receptor, and to precipitate a molecule of 48,000-62,000 mol wt in size from radioiodinated mouse T cell membranes. The latter is analogous to the characteristics of the IL-2 receptor on activated human T cells (26) . Furthermore, affinity-purified human IL-2 blocks the binding of 3C7 to T cells. This led to the conclusion that 3C7 is specific for the mouse IL-2 receptor and that it competes with IL-2 for binding to that receptor (12) . Although 3C7 did not show any effect on proliferation of B cells stimulated with anti-IgM and BSFpl (K. Nakanishi and T. Malek, unpublished observations), ascitic fluid containing 3C7 showed substantial, although incomplete, inhibition of the EL-TRF activity of low molecular weight EL-TRF from SDS-PAGE (Table I , Exp. 1). This fraction contained 70 U/ml of IL-2, as judged by the HT-2 assay. By 2 ) were pooled, concentrated, and applied to a 12.5% polyacry[amide slab gel containing 1% SDS and electrophoresed for 6 h at a constant voltage of 150 V. Standards used were BSA (tool wt 68,000), OVA (mol wt 43,000), a-chymotripsinogen (mol wt 25,700), B-lactoglobulin (mol wt 18,400), and cytochrome c (mol wt 12,300). Fractions (2 ml) were electroeluted, dialyzed, and tested for IL-2, BSF-pl, and ELoTRF activity.
contrast, 3C7 had no inhibitory action on the EL-TRF activity of high molecular weight EL-TRF, which had no measurable IL-2 activity.
This result was confirmed in a second experiment (Table I, Exp. 2) in which molecularly cloned human IL-2 was examined for its capacity to mimic EL-TRF by causing IgM synthesis in B cells cultured with anti-IgM, BSF-pl, and B15-TRF. The differentiative activity of low molecular weight EL-TRF was diminished by 76% by 3C7, in comparison with the result obtained with 50C1, a control ascitic fluid. 3C7 caused no inhibition of stimulation of Ig synthesis by high molecular weight EL-TRF. Cloned IL-2, obtained from Hoffman-La Roche, Inc., at concentrations of 100-1,000 U/ml caused IgM synthesis in the presence of anti-IgM, BSF-pl, and B15-TRF; maximum responses required 500 U/ml. This stimulation was inhibited by 3C7; the degree of inhibition was greatest when the lowest concentrations of IL-2 were used.
In separate experiments, comparable results were obtained with molecularly cloned human IL-2 provided to us by Cetus Corporation. 1,000 U of IL-2 were required for maximal IgM synthesis with this material. This should contain 0.67 pg of endotoxin, which is far too low to induce B cell differentiation in the presence ofanti-IgM (data not shown). This, together with the specific inhibitory effect of 3C7 on IL-2-induced IgM synthesis, indicates that small amounts of Fig. 5) . At all concentrations of IL-2, from 31 to 8,000 U/ml, the addition of fraction 13 caused a greater than additive enhancement of the concentration of cytoplasmic IgM in the stimulated cell population. The mechanism underlying this synergistic effect of IL-2 and high molecular weight EL-TRF remains to be elucidated. However, this effect may explain why pH 4.5 fractions of isoelectric focusing (IEF) separations of EL-4 supernatant, which contained relatively small amounts of IL-2 (50 U/ml), n o n e t h e l e s s gave very substantial E L -T R F activity in o u r initial studies (4) 
o m S e p h a d e x G-150. T h i s f r a c t i o n c o n t a i n s b o t h h i g h m o l e c u l a r w e i g h t E L -T R F , a n d IL-2, p r e s u m a b l y in a d i m e r i c f o r m .
Expression of IL-2 Receptors on Activated B Cells. I f the B cells a r e the d i r e c t t a r g e t o f IL-2, t h e n t h e y s h o u l d e x p r e s s r e c e p t o r s for this l y m p h o k i n e . W e e x a m i n e d this in two ways. First, we t e s t e d the capacity o f m o n o c l o n a l a n t i b o d i e s to the T cell IL-2 r e c e p t o r to b i n d to B cells; second, we tested b i o s y n t h e t i c a l l y r a d i o l a b e l e d IL-2 for b i n d i n g to B cells. B cells w e r e s t i m u l a t e d with a n t i -I g M a n d B S F -p l with o r w i t h o u t B 1 5 -T R F
for 2 d. Cells harvested at that time consisted almost exclusively of IgM-bearing cells; no Thy-l-bearing cells were detected (Fig. 6A) . This indicates the purity of the cell population used in these studies. B cells stimulated with anti-IgM, BSF-pl, and B15-TRF bind small but significant amounts of 3C7 (Fig. 6B) and somewhat greater amounts of 7D4 (Fig. 6C) . The specificity of this binding is shown by its inhibition by preincubation with the homologous unlabeled monoclonal antibody but not by a monoclonal antibody of the same class that is not specific for the IL-2 receptor. The greater fluorescence intensity of B cells stained with FITC-7D4 may reflect the fact that FITC-7D4 has a higher fluorescein-to-protein ratio than FITC-3C7 and that it is an IgM whereas 3C7 is an IgG. B cells incubated with anti-IgM, BSF-pl, and B15-TRF bind somewhat more FITC-3C7 and FITC-7D4 than do B cells incubated with anti-IgM and BSF-pl, only (Fig. 7) . This suggests that B15-TRF may slightly enhance the expression of IL-2 receptors on activated B cells.
To compare the expression of antigens recognized by 3C7 and 7D4 on stimulated B cells and on cells from an IL-2-dependent T cell line (HT-2 cells), we carried out indirect immunofluorescence studies using FITC-MAR 18.5 to detect binding of 3C7 and 7D4. Fig. 8 illustrates results using B cells cultured with anti-IgM, BSF-pl, and B15-TRF for 3 d and HT-2 cells fed with IL-2 2 d previously. We determined the mean fluorescence intensities of HT-2 cells and of stimulated B cells stained with 3C7, 7D4, or SP2/O ascitic fluid, followed by FITC-MAR 18.5. Using these data, we estimate that HT-2 cells bound 125-fold more 3C7 and 56-fold more 7D4 than did B cells stimulated with anti-IgM, BSFpl, and B15-TRF.
The B cell preparation used in the experiment described in Fig. 6 was also tested for its capacity to bind radiolabeled human IL-2. B cells cultured for2 d with anti-IgM, BSF-p 1, and B 15-TRF were incubated with various concentrations of [3H]IL-2, ranging from 0.31 to 2 nM (Fig. 9) . At the highest concentration of (4) . In the present studies, we found that IL-2, which is present in such supernatants at a relatively high concentration, has such EL-TRF activity. The evidence that supports this conclusion is that IL-2 and EL-TRF activity co-migrate on gel filtration and that IL-2 and low molecular weight EL-TRF activity co-electrophorese on SDS-PAGE. The activity of low molecular weight EL-TRF is inhibited by 3C7, a monoclonal antibody to the mouse IL-2 receptor, and molecularly cloned IL-2 exhibits EL-TRF activity which can be blocked by 3C7. Not only did IL-2 prove to have EL-TRF activity by measurement of the induction of cytoplasmic IgM, it also caused an 8-16-fold increase in levels of mRNA for the secretory form of # heavy chains when used on B cells cocultured with anti-IgM, BSF-pl, and B15-TRF. An important observation regarding the action of IL-2 as EL-TRF is that high concentrations (100 U/ml and above) of this lymphokine are required for induction of IgM synthesis. We will discuss this point in greater detail below.
Since we used very highly purified B cells, it seemed quite likely that IL-2 was acting directly upon B cells. However, IL-2 can stimulate activated T cells to secrete factors such as BSF-pl (27) and ~,-interferon (28, 29) . Thus, the possibility must be considered that IL-2 is acting indirectly, by stimulating residual T cells The high concentrations of IL-2 required for EL-TRF activity need further consideration. This requirement could be partly explained if it is postulated that B or T cell responses to IL-2 require the binding of IL-2 to a fixed number of IL-2 receptors per cell. The formation of a specific number of IL-2-receptor complexes would depend upon the free concentrations of both IL-2 and IL-2 receptors. Thus, if one cell type bore fewer IL-2 receptors than a second cell type, a greater concentration of free IL-2 would be required to cause the latter cell to achieve comparable numbers of bound receptors. However, we do not believe such an argument can completely explain the requirement for high concentrations of IL-2 to stimulate B cells. First, such an argument assumes that both B and T cell responses require that similar numbers of receptors must be occupied. No evidence exists on this point. Second, the concentrations of IL-2 required to cause B cell differentiation appear to be in excess of those necessary to saturate T cell receptors for IL-2, even when T cell IL-2 receptors are present at much higher number than B cell IL-2 receptors. We base this on calculations of the concentrations of IL-2 required for stimulating B cell activation and for saturating T cell IL-2 receptors. Cantrell and Smith (25) have reported that 1 U/ml of affinity-purified IL-2 is equivalent to 5.3 × 10 -l~ M. 2 Thus, 100 U/ml, the concentration of IL-2 required for effects on B cells cultured at 2 × 105/ well, would be 5.3 nM. Assuming that no substantial amounts of IL-2 are consumed in these B cell cultures (consistent with bound/free ratios observed in our binding experiments), the available amount of IL-2 should be more than sufficient to saturate receptors on HT-2 cells cultured at densities similar to those at which the B cells are cultured. In the binding study presented in Fig. 9 , a total concentration of -0.8 nM of IL-2 essentially saturated the IL-2 receptors of 5 × 105 HT-2 cells. This result suggests that the affinity of the B cell receptor for IL-2 is lower than that detected on HT-2 cells. The initia ! binding data reported in Fig. 9 is consistent with this possibility. Such a difference is reminiscent of the affinity of binding sites for macrophage-specific colony-stimulating activity (CSA-M) when examined by competitive binding using lineage-specific CSAs. Granulocyte-specific CSA (CSA-G) competes for CSA-M binding to its receptor, but 100-fold higher CSA-G concentrations are required compared with those of CSA-M (32) .
The action of IL-2 in causing B cells to differentiate to high rate IgMsynthesizing cells is dependent upon their treatment with B15-TRF. Without B 15-TRF, neither enhancement in levels of mRNA for the secretory form of heavy chains nor the presence of cells with cytoplasmic IgM is observed. However, B cells cultured with anti-IgM and BSF-p 1, without B 15-TRF, do express epitopes recognized by 3C7 and 7D4 and these stimulated B cells can bind small amounts of [3H]IL-2. Thus, the expression of IL-2 receptors on B cells does not appear to depend upon the presence of B15-TRF. Fluorescence histograms of binding of 3C7 and 7D4 to B cells indicate that B15-TRF-treated B cells do bind somewhat more 3C7 and 7D4 than activated B cells not cultured with this factor. Whether this modest increase in receptor expression difference accounts for the differences in responsiveness to IL-2 or whether the action of B1B-TRF as a B cell differentiation molecule is mediated through a distinct mechanism, not dependent in changes in expression of IL-2 receptors, cannot be answered at this time.
These results also support the concept that IL-2 is not limited in its function to the stimulation of proliferation. Thus, its action on B cells appears to be principally to cause Ig synthesis. We have not detected evidence that IL-2 drives B cell proliferation directly. The possibility that IL-2 causes a terminal round of B cell proliferation that may be necessary for Ig synthesis has, however, not been excluded.
Our results also indicate the existence in induced EL-4 supernatants of a high molecular weight EL-TRF. This material, which has an apparent molecular weight of 32,000 by gel filtration and SDS-PAGE, lacks both IL-2 and BSF-p1 activity. Its structure and its relation to other differentiation factors has not yet been defined. However, no interferon activity was detected in high molecular weight EL-TRF using as an assay interference of the infection of L cells by vesicular stomatitis virus (T. Hecht, personal communication). Similarly, a sample of genetically cloned mouse "r-interferon provided to us by Dr. P. Gray (Genentech, Inc., So. San Francisco, CA), did not display EL-TRF activity when added on the first day of culture.
The relative roles of high molecular weight EL-TRF and IL-2 as B cell differentiation factors in vivo will need to be carefully considered. This is particularly so because the need for very high concentrations of IL-2 to induce differentiation to high rate IgM synthesis of B cells activated with anti-IgM, BSFpl, and B15-TRF naturally raises the question of the physiologic significance of this process. Since information regarding the local concentrations of IL-2 in the immediate vicinity of IL-2-secreting cells in vivo is not yet available, it would be premature to reach a decision on this issue. One must entertain the possibility that IL-2 is not a physiologic ligand in promoting IgM secretion, but rather, another, as yet unidentified, activity is responsible for the B cell IgM secretion mediated through B cell IL-2-binding sites. Summary B cells cultured with anti-IgM, BSF-pl, and B15-TRF will differentiate into high rate IgM-synthesizing cells in the presence of supernatants from EL-4 cells that have been induced with phorbol myristate acetate. These supernatants contain two molecular species (EL-TRFs) that have differentiative activity. One co-migrates with interleukin 2 (IL-2) and its activity is blocked by antibody to the IL-2 receptor. Furthermore, molecularly cloned IL-2, at concentrations of 100 U/mi or more, expresses such EL-TRF activity. The EL-TRF activity of cloned IL-2 can also be inhibited by antibody to the IL-2 receptor. The other material with EL-TRF activity has a molecular weight of ~32,000. This material lacks IL-2 activity. Antibody to the IL-2 receptor does not impair its function.
B cells stimulated with anti-IgM and BSF-p 1, with or without B 15-TRF, express determinants that react with two monoclonal antibodies which recognize distinct epitopes on the T cell IL-2 receptor. These determinants are present at much lower density (~100-fold) on stimulated B cells than on HT-2 cells, an IL-2-dependent T cell line. Very small amounts of [3H]IL-2 (<1,000 molecules per cell) bind to activated B cells. These results indicate that IL-2 binds to a receptor on appropriately prepared B cells and causes them to differentiate into high rate IgM-synthesizing cells. The physiologic significance of the B cell differentiative activity of IL-2 remains to be investigated.
